We Australians should praise America for embracing Avita .My wife and I have held shares since the very early years and were listed number five on the shareholders list .We have followed these shares because we believed in what it could do for the benefit of the human race .When the product proved how good it was on the victims of the Barli bombings the medical profession only complained it was used before enough research had been conducted. Our management went from country to country trying to market recell without being successful .Then about 2012 an attempt was made to get FDA approval in America that stalled as I understand because of costs and our understanding of requirements .We thought our money and the dream of success had evaporated . American Army doctors liked Recell and came to our rescue and should be recognized for their knowledge, expertise and millions of money to not only have Recell accepted in America but used in all their hospitals. Now we have a company worth over a billion dollars and confident of gaining wide ranging use to earn up to two billion dollars a year from America alone.
- Forums
- ASX - By Stock
- Ann: ASIC Registers Scheme Booklet for Redomiciliation
We Australians should praise America for embracing Avita .My...
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.82 |
Change
0.140(3.80%) |
Mkt cap ! $266.9M |
Open | High | Low | Value | Volume |
$3.83 | $3.87 | $3.77 | $1.433M | 374.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3987 | $3.82 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.86 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3987 | 3.820 |
2 | 860 | 3.800 |
1 | 4 | 3.780 |
1 | 2000 | 3.770 |
1 | 7963 | 3.760 |
Price($) | Vol. | No. |
---|---|---|
3.860 | 200 | 1 |
3.870 | 9629 | 2 |
3.880 | 17056 | 3 |
3.890 | 6504 | 2 |
3.900 | 8380 | 3 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online